Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
174M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
+1.57M
-
Total reported value, excl. options
-
$780M
-
Value change
-
+$59.9M
-
Number of buys
-
38
-
Number of sells
-
-32
-
Price
-
$35.10
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q4 2017
79 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q4 2017.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 174M outstanding shares and own 12.75% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (7.51M shares), Redmile Group, LLC (2.21M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.73M shares), FMR LLC (1.11M shares), EcoR1 Capital, LLC (936K shares), BlackRock Inc. (935K shares), BB BIOTECH AG (856K shares), JANUS HENDERSON GROUP PLC (709K shares), PERCEPTIVE ADVISORS LLC (663K shares), and Boxer Capital, LLC (550K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.